S-ethylisothiouronium diethylphosphate

S-乙基异硫脲二乙基磷酸盐

Report date: 2022/03/02 14:28:36
NME

Base Information

Drug NameS-ethylisothiouronium diethylphosphate
Drug Alias NameS-ethylisothiourea diethylphosphateRavitenRavimigRaviclustDifetur +[11
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase, inducible modulators
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsHypotensionCluster HeadacheMigraine Disorders
Global Approved IndicationsHypotensionCluster HeadacheMigraine Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEurope
Original Approved Date1997/01/01
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypotensionCluster HeadacheMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeC